Economics
Pharma Stocks Struck as Drug Pricing Story Takes Its Toll
- A new price war set off by payers hurts S&P health-care index
- ‘We may be seeing the end of days,’ Baird analysts say
This article is for subscribers only.
It’s been a brutal October for health-care investors. The worst may be yet to come.
A year after presidential candidate Hillary Clinton first tweeted about outrageous price gouging, the reality of pricing pressure in the U.S. hit Wall Street in the most concrete way: earnings.